Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

Withdrawn applications

Get the latest updates from Withdrawn applications directly as they happen.

Follow now 197 followers

Latest posts

Last updated 4 days ago

Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Application withdrawn

4 days ago

Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes...

Veterinary medicines European public assessment report (EPAR): Sirolimus TriviumVet , sirolimus, Status: Application withdrawn

6 days ago

Veterinary medicines European public assessment report (EPAR): Sirolimus TriviumVet , sirolimus, Status...

Withdrawn application: Brilique, 15/12/2021

19 days ago

Withdrawn application: Brilique, 15/12/2021

Withdrawn application: Vectra 3D, 27/11/2024

21 days ago

Withdrawn application: Vectra 3D, 27/11/2024

Human medicines European public assessment report (EPAR): Ohtuvayre, ensifentrine, Status: Application withdrawn

about 1 month ago

Human medicines European public assessment report (EPAR): Ohtuvayre, ensifentrine, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Insulin Aspart Injection, insulin aspart, Status: Application withdrawn

about 1 month ago

Human medicines European public assessment report (EPAR): Insulin Aspart Injection, insulin aspart...

Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Application withdrawn

about 1 month ago

Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Datopotamab deruxtecan Daiichi Sankyo, datopotamab deruxtecan, Status: Application withdrawn

about 1 month ago

Human medicines European public assessment report (EPAR): Datopotamab deruxtecan Daiichi Sankyo, datopotamab...

Human medicines European public assessment report (EPAR): Insulin Human Rechon, insulin human, Status: Application withdrawn

about 2 months ago

Human medicines European public assessment report (EPAR): Insulin Human Rechon, insulin human...

Human medicines European public assessment report (EPAR): Hydrocortisone Aguettant, Status: Application withdrawn

about 2 months ago

Human medicines European public assessment report (EPAR): Hydrocortisone Aguettant, Status: Application withdrawn

Withdrawn application: Sileo, 30/08/2022

2 months ago

Withdrawn application: Sileo, 30/08/2022

Human medicines European public assessment report (EPAR): Nidlegy, bifikafusp alfa,onfekafusp alfa, Status: Application withdrawn

3 months ago

Human medicines European public assessment report (EPAR): Nidlegy, bifikafusp alfa,onfekafusp alfa, Status...